Materials • Major Chemicals
$0.48 ▲ +0.00
(+0.50%)
MKT CAP: $2.7M • VOL: 40.0K
52W L $0 52W H $3
ROARABLE / RQD
D • 44/100
PIOTROSKI
2 / 9
CNEY // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-09-30 | FY 2024
FILED 2024-09-30 | FY 2023
FILED 2023-09-30 |
|---|---|---|---|
| Revenue (Total Sales) | $35.6M | $51.0M | $57.9M |
| YoY Revenue Growth % | -30.2% | -12.0% | — |
| Gross Profit | $647.6K | -$181.1K | — |
| Gross Margin % | 1.8% | -0.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$11.0M | -$12.5M | -$6.2M |
| Operating Margin % | -30.9% | -24.5% | -10.7% |
| Net Income (GAAP) | -$11.1M | -$14.0M | -$5.6M |
| EBITDA (Normalized) | -$11.0M | -$12.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$2.0M | -$2.4M | -$30.2M |
| Capital Expenditures (CapEx) | $0 | $0 | — |
| Free Cash Flow (FCF) | -$2.0M | -$2.4M | -$30.2M |
| FCF Margin % | -5.5% | -4.7% | -52.1% |
| Return on Invested Capital (ROIC %) | — | — | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | — | — | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR CNEY.